Eandi M. Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer. Farmeconomia. Health Economics and Therapeutic Pathways. 2006;7(2):97-117. https://doi.org/10.7175/fe.v7i2.680